Abstract: An arrangement for laser treatment of vitreous floaters. The arrangement for laser vitreolysis of an eye includes an OCDR system, a laser system having a deflection unit, optical elements that couple the OCDR system and the laser system, a display unit and a central control and operating unit. The OCDR system is configured to localize the position of a floater along the optical axis of the OCDR system. The laser system is configured to destroy the floaters by application of laser pulses, and the central control and operating unit is configured to focus the laser system onto the position of the floater and to activate it, in particular when the position of the laser focus and the floater match in a sufficient manner. The present invention relates to an arrangement for the gentle, low risk and painless laser treatment of vitreous floaters, which allows a partially or fully automated therapy.

Abstract: A device and method for the pre-display of a spot pattern to be applied for a laser treatment of the eye. The spot patterns to be applied are displayed to the operator in advance with the aid of a target beam. The device for the pre-display of a spot pattern to be applied for a laser treatment of the eye includes a laser system and a scanning system for generating a target beam. Here, the laser system and the scanning system for generating the target beam are formed to generate one or more lines which overlie all the spots of the spot pattern of a planned laser treatment. The device and method are suitable for laser treatment of the retina, the trabecular meshwork as well as other regions. Here, it is irrelevant whether what the laser treatment to be applied is.

Abstract: An arrangement for OCT-based laser treatment of vitreous floaters. The arrangement for OCT-based laser vitreolysis includes an OCT system, a laser system having a deflection unit, optical elements that couple the OCT system and the laser system, a display unit and a central control and operating unit. The OCT system is configured to localize the floaters, the laser system is configured to destroy the floaters by application of laser pulses and the central control and operating unit is configured to determine apart from the coordinates of the localized floaters also their distance to structures of the eye, to derive exclusion criteria for the treatment, to align the deflection unit of the laser system to these coordinates and to focus and activate the laser system. The present invention relates to an arrangement for the gentle, low risk and painless laser treatment of vitreous floaters, which enables partially or fully automated therapy.

Abstract: A device for superimposing parameters and/or image data in the stereoscopic observation path of ophthalmological devices relates to an apparatus for reflecting relevant parameters and/or image data into the stereoscopic observation beam path of ophthalmic devices, for example for therapeutic laser treatments of an eye. The device includes an additional micro-display, which is connected to the control unit, and a beam deflection element for reflecting the parameters and/or image data shown on the micro-display into the stereoscopic observation beam path, which are for example arranged in the parallel beam path. Even though the apparatus is intended for ophthalmic devices for therapeutic laser treatment in the eye, it can also be used, in principle, for ophthalmic devices for examination, diagnosis and surgical interventions.

Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.

Abstract: An artificial eye lens having an integral optical part which has, viewed in the direction of an optical principal axis of the eye lens, a first optical side and an opposite, second optical side. The optical part is formed with a structure having birefringence, where the birefringent structure in the integral optical part is formed as a laser structure. A method for producing an artificial eye lens, where the birefringent structure is produced with a laser apparatus, and a pulsed laser beam having a pulse length of between 100 fs and 20 ps, a wavelength of between 320 nm and 1100 nm, a pulse repetition rate of between 1 kHz and 10 MHz, a focus diameter of less than 5 ?m, and a power density of greater than 106 W/cm2.

Abstract: A device and a method for the femtosecond laser surgery of tissue, especially in the vitreous humor of the eye. The device includes an ultrashort pulse laser with pulse widths in the range of approximately 10 fs-1 ps, especially approximately 300 fs, pulse energies in the range of approximately 5 nJ-5 ?J, especially approximately 1-2 ?J and pulse repetition rates of approximately 10 kHz-10 MHz, especially 500 kHz. The laser system is coupled to a scanner system which allows the spatial variation of the focus in three dimensions (x, y and z). In addition to the therapeutic laser/scanner optical system, the device includes a navigation system.

Abstract: A method for collecting biometric measurement data of an eye on the basis of different measurement modalities, allowing for physiologically correct, representative, and robust biometric measurement data. In the method, the measurement data for individual measurement variables and the dynamic behavior of the eye are recorded continuously at the highest possible repetition rate over the measurement time. The individual phases of the dynamics of the eye which define the limits of the phase for stable vision are analyzed on the basis of the measurement values, and only the measurement data for the individual measurement variables are output which have been detected during the phase for stable vision. Although the proposed method is provided for collecting biometric measurement data in preparation for a cataract operation, the method can also be applied to other areas of ophthalmology to generate error-free measurement data or recordings of the eye.

Abstract: The invention relates to a method for controlling a semiconductor-laser-diode-based SS-interferometer system (SS=swept source), which allows for a wide range of application and is suitable for use in ophthalmology, in particular for imaging and for determining biometric measurement values of the eye. In the method according to the invention, by means of periodic current modulation, the operation of single semiconductor laser diodes is designed such that a highly coherent spectral laser line can be adjusted with a highest possible repetition rate and over a wide wavelength range. In addition, the following parameters: centre wavelength, sweep rate, sweep range, optical power in the eye and coherence length are adjusted such that the method is suitable for imaging and biometric applications via whole-eye scans. The proposed semiconductor-laser-diode-based SS-interferometer system is provided, in particular, for biometric measuring of the eye.

Abstract: A method for detecting structures within an optical element of an eye and processing the optical element as a function of the detected structures includes acquiring, by a detection device, geometric data of an eye, transferring, by the detection device, the geometric data of the eye to a controller, calculating, by the controller, target coordinates for a processing device including a laser, the processing device being connected to the controller, and applying a beam produced by the laser to the eye according to the target coordinates calculated by the controller so as to process the optical element.

Abstract: The invention relates to an artificial eye lens comprising an optical part, which has a first optical side as viewed in a direction of an optical principal axis of the artificial eye lens and an opposite second optical side, wherein a structure with at least one depression is formed in a haptic arrangement of the artificial eye lens and/or in a surround that surrounds the optical part at least in certain areas and that differs from the haptic arrangement, wherein the structure is formed as a micro-perforation with a multiplicity of perforation zones and at least some perforation zones are filled at least in certain areas with at least one medicament for the purposes of producing a medicament repository. The invention also relates to a method for producing such an artificial eye lens.

Abstract: A method for detecting structures within an optical element of an eye and processing the optical element as a function of the detected structures includes acquiring, by a detection device, geometric data of an eye, transferring, by the detection device, the geometric data of the eye to a controller, calculating, by the controller, target coordinates for a processing device including a laser, the processing device being connected to the controller, and applying a beam produced by the laser to the eye according to the target coordinates calculated by the controller so as to process the optical element.

Abstract: An artificial eye lens (1) having an optical part (2) which has a first optical side (4) and an opposite, second optical side (5). The optical part (2) has a diffractive grating structure that contributes to an optical imaging property of the optical part (2). The diffractive grating structure is an amplitude grating (6) formed in the optical part (2) as a laser structure. A method for producing an artificial eye lens (1) where the amplitude grating (6) is produced with a laser apparatus (17), and a pulsed laser beam (22) having a pulse length of between 100 fs and 20 ps, a wavelength of between 320 nm and 1100 nm, a pulse repetition rate of between 1 kHz and 10 MHz, a focus diameter of less than 5 ?m, and a power density of greater than 106 W/cm2.

Abstract: A planning system for generating control data for a treatment apparatus which creates at least one cut surface in the cornea using a laser device, and a treatment apparatus which comprises a planning system of the aforementioned type. The invention also relates to a method of generating control data for a treatment apparatus which creates at least one cut surface in the cornea using a laser device, and to a corresponding method of eye surgery. The planning system comprises a calculation means for defining the cut surfaces of the cornea, wherein the calculation means determines the cornea cuts so that the cut surfaces isolate a lenticule, which is treated according to the planned refraction correction after removal from the cornea, so that the planned refraction correction occurs after the insertion into the cornea of the recipient.

Abstract: A laser therapy device includes: a solid-state laser for a CW operation and including a pump source; and a controller for generating at least one first pulse of the laser in a first-pulse operation, the controller switching on the pump source to a pump power level S1 at least once during the first-pulse operation. A rise time E, after which the pump power level S1 of the pump source is attainable and starting from the time the pump source is switched on, is in a range of 50 ns to 350 ns.

Abstract: An intraocular implant, such as a corneal implant, an intraocular lens or an IOL carrier matrix, which has a dimensionally stable lattice structure and a corresponding method for producing an intraocular implant. The intraocular implant and method for producing an intraocular implant counteract metabolic problems, and thus also limited functional compatibility, and facilitates long-term tolerance. The intraocular implant has a dimensionally stable lattice structure designed in such a way that it permits permeability for small molecules and/or supports the mobility of endogenous cells in the implant.

Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.

Abstract: An artificial eye lens having an integral optical part which has, viewed in the direction of an optical principal axis of the eye lens, a first optical side and an opposite, second optical side. The optical part is formed with a structure having birefringence, where the birefringent structure in the integral optical part is formed as a laser structure. A method for producing an artificial eye lens, where the birefringent structure is produced with a laser apparatus, and a pulsed laser beam having a pulse length of between 100 fs and 20 ps, a wavelength of between 320 nm and 1100 nm, a pulse repetition rate of between 1 kHz and 10 MHz, a focus diameter of less than 5 ?m, and a power density of greater than 106 W/cm2.

Abstract: A planning device for generating control data for a treatment apparatus which by means of a laser device produces at least one incision surface in the cornea, and to a treatment apparatus having such a planning device. The invention further relates to a method for generating control data for a treatment apparatus which by using a laser device produces at least one incision surface in the cornea, and to a corresponding ophthalmic surgery method. The planning device is thereby provided with calculation means for defining the corneal incision surfaces, wherein the calculation means determine the corneal incision surfaces on the basis of data of a LIRIC structure and/or a refractive correction, and generate for the corneal incision surfaces a control data set for controlling the laser device, wherein the calculation means determine the corneal incision surfaces in such a manner that the LIRIC structure is enclosed by the incision surfaces.

Abstract: The invention relates to an artificial eye lens comprising an optical part, which has a first optical side as viewed in a direction of an optical principal axis of the artificial eye lens and an opposite second optical side, wherein a structure with at least one depression is formed in a haptic arrangement of the artificial eye lens and/or in a surround that surrounds the optical part at least in certain areas and that differs from the haptic arrangement, wherein the structure is formed as a micro-perforation with a multiplicity of perforation zones and at least some perforation zones are filled at least in certain areas with at least one medicament for the purposes of producing a medicament repository. The invention also relates to a method for producing such an artificial eye lens.